What question did this study set out to answer?

This essay explores the potential link between mRNA vaccination for SARS-CoV-2 and the onset of autoimmune diseases, particularly type 1 diabetes.

April 30, 2026Open Access

Autoimmune Phenomena and New‐Onset Type 1 Diabetes Following SARS‐CoV‐2 Vaccination: A Personal Perspective

Key Points

This essay explores the potential link between mRNA vaccination for SARS-CoV-2 and the onset of autoimmune diseases, particularly type 1 diabetes.
Personal narrative discussing the author's experience and observations.
Integration of molecular biology insights regarding vaccination and autoimmune responses.
Documented case of new-onset type 1 diabetes following mRNA vaccination against SARS-CoV-2.
Reflection on ongoing challenges and therapeutic prospects for managing autoimmune disease.

Abstract

A molecular biologist whose wife suddenly developed type I diabetes in the summer of 2022 addresses the possible risk of developing autoimmune disease from messenger RNA (mRNA) vaccination against SARS-CoV-2. This essay also provides a record of the tough fight against autoimmune disease continuing to the present day, the prospect for therapeutics to control type I diabetes, and the author's for standing by his wife.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Kimihiko Sugaya

Journals

Immunity Inflammation and Disease

Actions

Institutions

National Institutes for Quantum Science and Technology

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Autoimmune Phenomena and New‐Onset Type 1 Diabetes Following SARS‐CoV‐2 Vaccination: A Personal Perspective

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study